AW
MET icon

ACG Wealth’s MetLife MET Stock Holding History

ACG Wealth’s Portfolio MET Stock Details MET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3
Closed – – 707
2022
Q2 		$0 Buy
+3
New +$199 ﹤0.01% 1009

Other funds holding MET

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

ACG Wealth's MET Position: Q3 2022 in Review

ACG Wealth sold out of MetLife (MET) in Q3 2022, closing a stake of 3 shares.

ACG Wealth first reported a position in MET in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 1,194 funds tracked by Wall St. Rank hold MET as of Q3 2022.

  • ACG Wealth reported no remaining MetLife position as of Q3 2022 after selling out during the quarter.
  • ACG Wealth sold 3 MetLife shares in Q3 2022.
  • ACG Wealth first reported a position in MetLife in Q2 2022 and held it in 1 quarter.
  • ACG Wealth's MetLife position peaked at $0 in Q2 2022.
  • 1,194 funds tracked by Wall St. Rank held MetLife as of Q3 2022.

Based on ACG Wealth's 13F filing for Q3 2022, filed 3 Nov 2022.